ZEESHAN KHAN: Open Payments
NPI 1144668864 · OCEANSIDE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,022 in 89 payments from 23 companies in 2025. Trend: 2023 $1,506 · 2024 $1,348 · 2025 $2,022
Food & beverage: $2,022
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $229 |
| Axsome Therapeutics, Inc. | 12 | $223 |
| Otsuka America Pharmaceutical, Inc. | 7 | $161 |
| PFIZER INC. | 7 | $143 |
| Lilly USA, LLC | 6 | $132 |
| Novo Nordisk Inc | 5 | $116 |
| AstraZeneca Pharmaceuticals LP | 6 | $112 |
| Corcept Therapeutics | 5 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $99 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
Products named: CAPLYTA, Auvelity, REXULTI, JARDIANCE, Korlym, DUPIXENT, ELIQUIS, XIFAXAN.
Industry payments across NY — which companies pay providers there.
